RU94019333A - Применение физиологически допустимого, корпускулярного ферримагнитного или ферромагнитного материала, способ формирования магнитометрического изображения, процесс обнаружения изменений, применение физиологически допустимых парамагнитных, сверхпарамагнитных, ферромагнитных или ферримагнитных частиц, устройство формирования изображения - Google Patents

Применение физиологически допустимого, корпускулярного ферримагнитного или ферромагнитного материала, способ формирования магнитометрического изображения, процесс обнаружения изменений, применение физиологически допустимых парамагнитных, сверхпарамагнитных, ферромагнитных или ферримагнитных частиц, устройство формирования изображения

Info

Publication number
RU94019333A
RU94019333A RU94019333/14A RU94019333A RU94019333A RU 94019333 A RU94019333 A RU 94019333A RU 94019333/14 A RU94019333/14 A RU 94019333/14A RU 94019333 A RU94019333 A RU 94019333A RU 94019333 A RU94019333 A RU 94019333A
Authority
RU
Russia
Prior art keywords
ferromagnetic
physiologically acceptable
forming
corpuscular
image
Prior art date
Application number
RU94019333/14A
Other languages
English (en)
Other versions
RU2137501C1 (ru
Inventor
Клавенесс Йо
No]
Эге Торфинн
М. Роклейдж Скотт
Us]
Original Assignee
Нюкомед Имагинг Ас (No)
Нюкомед Имагинг АС
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нюкомед Имагинг Ас (No), Нюкомед Имагинг АС filed Critical Нюкомед Имагинг Ас (No)
Publication of RU94019333A publication Critical patent/RU94019333A/ru
Application granted granted Critical
Publication of RU2137501C1 publication Critical patent/RU2137501C1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1887—Agglomerates, clusters, i.e. more than one (super)(para)magnetic microparticle or nanoparticle are aggregated or entrapped in the same maxtrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1857—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Изобретение обеспечивает применение физиологически допустимого, корпускулярного, свободного или кристаллического происхождения, ферромагнитного или ферримагнитного материала для приготовления диагностического агента для ввода в кишечно-желудочный тракт, репродуктивный тракт, мочевой тракт, замкнутые полости тела (например, в синовиальную жидкость или сосуды) или мускулатуру для формирования магнитометрического изображения человеческого или нечеловеческого животного тела.

Claims (1)

  1. Изобретение обеспечивает применение физиологически допустимого, корпускулярного, свободного или кристаллического происхождения, ферромагнитного или ферримагнитного материала для приготовления диагностического агента для ввода в кишечно-желудочный тракт, репродуктивный тракт, мочевой тракт, замкнутые полости тела (например, в синовиальную жидкость или сосуды) или мускулатуру для формирования магнитометрического изображения человеческого или нечеловеческого животного тела.
RU94019333A 1991-09-26 1992-09-26 Применение физиологически допустимого, корпускулярного ферримагнитного или ферромагнитного материала, способ формирования магнитометрического изображения, процесс обнаружения изменений, применение физиологически допустимых парамагнитных, сверхпарамагнитных, ферромагнитных или ферримагнитных частиц, устройство формирования изображения RU2137501C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9120508.8 1991-09-26
GB919120508A GB9120508D0 (en) 1991-09-26 1991-09-26 Diagnostic agents
PCT/EP1992/002254 WO1993005818A1 (en) 1991-09-26 1992-09-26 Diagnostic agents

Publications (2)

Publication Number Publication Date
RU94019333A true RU94019333A (ru) 1996-08-20
RU2137501C1 RU2137501C1 (ru) 1999-09-20

Family

ID=10702022

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94019333A RU2137501C1 (ru) 1991-09-26 1992-09-26 Применение физиологически допустимого, корпускулярного ферримагнитного или ферромагнитного материала, способ формирования магнитометрического изображения, процесс обнаружения изменений, применение физиологически допустимых парамагнитных, сверхпарамагнитных, ферромагнитных или ферримагнитных частиц, устройство формирования изображения

Country Status (8)

Country Link
US (2) US5496534A (ru)
EP (1) EP0605563A1 (ru)
JP (1) JPH06510777A (ru)
AU (1) AU662927B2 (ru)
CA (1) CA2116675A1 (ru)
GB (1) GB9120508D0 (ru)
RU (1) RU2137501C1 (ru)
WO (1) WO1993005818A1 (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2524974C2 (ru) * 2008-12-12 2014-08-10 Конинклейке Филипс Электроникс Н.В. Устройство и способ измерения локальной скорости жидкости
RU2525946C2 (ru) * 2008-12-08 2014-08-20 Конинклейке Филипс Электроникс Н.В. Конструкция и способ для обнаружения и/или определения местонахождения магнитного материала в области воздействия

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120508D0 (en) * 1991-09-26 1991-11-06 Nycomed As Diagnostic agents
US5674468A (en) * 1992-03-06 1997-10-07 Nycomed Imaging As Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons
DE19503664C2 (de) * 1995-01-27 1998-04-02 Schering Ag Magnetorelaxometrische Detektion von Analyten
US5842986A (en) 1995-08-16 1998-12-01 Proton Sciences Corp. Ferromagnetic foreign body screening method and apparatus
US6496713B2 (en) 1996-06-25 2002-12-17 Mednovus, Inc. Ferromagnetic foreign body detection with background canceling
US7047059B2 (en) * 1998-08-18 2006-05-16 Quantum Magnetics, Inc Simplified water-bag technique for magnetic susceptibility measurements on the human body and other specimens
US20020115925A1 (en) * 1996-06-25 2002-08-22 Avrin William F. Ferromagnetic foreign body detection utilizing eye movement
US6965792B2 (en) * 1996-06-25 2005-11-15 Mednovus, Inc. Susceptometers for foreign body detection
GB2319253A (en) 1996-11-16 1998-05-20 Eric Leigh Mayes Composition, for use in a device, comprising a magnetic layer of domain-separated magnetic particles
US6986942B1 (en) 1996-11-16 2006-01-17 Nanomagnetics Limited Microwave absorbing structure
US6815063B1 (en) 1996-11-16 2004-11-09 Nanomagnetics, Ltd. Magnetic fluid
US6713173B2 (en) 1996-11-16 2004-03-30 Nanomagnetics Limited Magnetizable device
WO1998037826A1 (de) * 1997-02-26 1998-09-03 Aesculap Meditec Gmbh Marker zur bestimmung seiner position in einem hohlraum innerhalb des organismus eines lebewesens
US6470220B1 (en) * 1999-03-29 2002-10-22 The Regents Of The University Of California Diagnosis and treatment of cancers using in vivo magnetic domains
JP4171139B2 (ja) * 1999-07-21 2008-10-22 住友電気工業株式会社 磁性体標識による免疫検査方法とその装置
EP1526171A1 (en) * 2000-02-24 2005-04-27 Xcyte Therapies, Inc Simultaneous stimulation and concentration of cells
US6867041B2 (en) 2000-02-24 2005-03-15 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
US20030119185A1 (en) * 2000-02-24 2003-06-26 Xcyte Therapies, Inc. Activation and expansion of cells
US6797514B2 (en) 2000-02-24 2004-09-28 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
US20030235908A1 (en) * 2000-02-24 2003-12-25 Xcyte Therapies, Inc. Activation and expansion of cells
WO2001062895A2 (en) * 2000-02-24 2001-08-30 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
US7572631B2 (en) * 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US7541184B2 (en) * 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
WO2001089539A2 (en) * 2000-05-25 2001-11-29 Xcyte Therapies, Inc. Methods for restoring or enhancing t-cell immune surveillance following naturally or artifically induced immunosuppression
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
DE10151778A1 (de) * 2001-10-19 2003-05-08 Philips Corp Intellectual Pty Verfahren zur Ermittlung der räumlichen Verteilung magnetischer Partikel
US6693426B1 (en) * 2002-02-09 2004-02-17 Intematix Corporation Spatially resolved spin resonance detection
US20030083588A1 (en) * 2001-10-29 2003-05-01 Mcclure Richard J. Pre-screening utilizing magnetic resonance imaging field
US20030216632A1 (en) * 2001-10-29 2003-11-20 Mednovus, Inc. Ferromagnetic sensing method and apparatus
US20040175373A1 (en) * 2002-06-28 2004-09-09 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
WO2004003142A2 (en) * 2002-06-28 2004-01-08 Xcyte Therapies, Inc. Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
AU2003300359A1 (en) * 2003-05-08 2004-12-13 Xcyte Therapies, Inc. Generation and isolation of antigen-specific t cells
WO2005030251A1 (en) * 2003-09-22 2005-04-07 Xcyte Therapies, Inc. Compositions and methods to accelerate hematologic recovery
US8118754B1 (en) 2007-11-15 2012-02-21 Flynn Edward R Magnetic needle biopsy
US7309316B1 (en) 2004-03-01 2007-12-18 Flynn Edward R Magnetic needle biopsy
US8060179B1 (en) 2006-11-16 2011-11-15 Scientific Nanomedicine, Inc. Biomagnetic detection and treatment of Alzheimer's Disease
US20050283226A1 (en) * 2004-06-18 2005-12-22 Scimed Life Systems, Inc. Medical devices
ES2255830B1 (es) * 2004-08-06 2007-07-16 Daniel Serrano Gil Disposicion para detectar la presencia de acumulaciones celulares hiperactivas en un organismo animal y procedimiento empleado en la deteccion.
US9964469B2 (en) 2005-02-28 2018-05-08 Imagion Biosystems, Inc. Magnetic needle separation and optical monitoring
JP4706075B2 (ja) * 2005-04-11 2011-06-22 学校法人金沢工業大学 磁気測定装置および磁気測定方法
US20090295385A1 (en) * 2005-05-11 2009-12-03 Audrius Brazdeikis Magneto Sensor System and Method of Use
WO2006122203A1 (en) * 2005-05-11 2006-11-16 The University Of Houston System An intraluminal magneto sensor system and method of use
EP1991577A2 (en) 2006-01-31 2008-11-19 Parkinson, John F. Modulation of mdl-1 activity for treatment of inflammatory disease
US8447379B2 (en) 2006-11-16 2013-05-21 Senior Scientific, LLC Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof
JP2008212505A (ja) * 2007-03-07 2008-09-18 Hitachi Ltd Ｍｒｉ装置
DE102007036570A1 (de) * 2007-08-03 2009-02-19 Siemens Ag Screeningtest zur Erkennung von Prostataerkrankungen sowie Vorrichtung und Diagnosesubstanz zur Durchführung des Tests
RU2519517C2 (ru) * 2009-04-30 2014-06-10 Конинклейке Филипс Электроникс Н.В. Устройство и способ для воздействия и/или обнаружения магнитных частиц и для магнитно-резонансной томографии
CA2780148C (en) 2009-11-06 2017-02-28 Scientific Nanomedicine, Inc. Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof
US10194825B2 (en) 2009-11-06 2019-02-05 Imagion Biosystems Inc. Methods and apparatuses for the localization and treatment of disease such as cancer
US8593141B1 (en) 2009-11-24 2013-11-26 Hypres, Inc. Magnetic resonance system and method employing a digital squid
US8970217B1 (en) 2010-04-14 2015-03-03 Hypres, Inc. System and method for noise reduction in magnetic resonance imaging
CA2902209A1 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
EP3412303A1 (en) 2017-06-08 2018-12-12 Medizinische Universität Innsbruck Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy
RU2685811C1 (ru) * 2018-06-04 2019-04-23 Климентий Николаевич Югай Способ обнаружения и ликвидации отдельных раковых клеток и их скоплений
US11136543B1 (en) 2020-02-11 2021-10-05 Edward R. Flynn Magnetic cell incubation device

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
GB8431305D0 (en) * 1984-12-12 1985-01-23 Ici Plc Extraction of metals
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US4813399A (en) * 1986-07-18 1989-03-21 Gordon Robert T Process for the treatment of neurological or neuromuscular diseases and development
US4996991A (en) * 1986-07-18 1991-03-05 Gordon Robert T Method for following the distribution of particles in neurological or neuromuscular tissue and cells
GB8813144D0 (en) * 1988-06-03 1988-07-06 Nycomed As Compositions
US5023072A (en) * 1988-08-10 1991-06-11 University Of New Mexico Paramagnetic/superparamagnetic/ferromagnetic sucrose sulfate compositions for magnetic resonance imaging of the gastrointestinal tract
WO1990007322A1 (en) * 1988-12-19 1990-07-12 David Gordon Diagnosis and treatment of viral effects
GB9007408D0 (en) * 1990-04-02 1990-05-30 Nycomed As Compositions
GB9120508D0 (en) * 1991-09-26 1991-11-06 Nycomed As Diagnostic agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2525946C2 (ru) * 2008-12-08 2014-08-20 Конинклейке Филипс Электроникс Н.В. Конструкция и способ для обнаружения и/или определения местонахождения магнитного материала в области воздействия
RU2524974C2 (ru) * 2008-12-12 2014-08-10 Конинклейке Филипс Электроникс Н.В. Устройство и способ измерения локальной скорости жидкости

Also Published As

Publication number Publication date
US5496534A (en) 1996-03-05
GB9120508D0 (en) 1991-11-06
EP0605563A1 (en) 1994-07-13
WO1993005818A1 (en) 1993-04-01
US5735279A (en) 1998-04-07
AU2655192A (en) 1993-04-27
AU662927B2 (en) 1995-09-21
CA2116675A1 (en) 1993-04-01
JPH06510777A (ja) 1994-12-01
RU2137501C1 (ru) 1999-09-20

Similar Documents

Publication Publication Date Title
RU94019333A (ru) Применение физиологически допустимого, корпускулярного ферримагнитного или ферромагнитного материала, способ формирования магнитометрического изображения, процесс обнаружения изменений, применение физиологически допустимых парамагнитных, сверхпарамагнитных, ферромагнитных или ферримагнитных частиц, устройство формирования изображения
DE69120403T2 (de) Verwendung von superparamagnetischen Partikeln zur magnetometrischen Untersuchungen (SQUID)
Weitschies et al. High-resolution monitoring of the gastrointestinal transit of a magnetically marked capsule
JP4444837B2 (ja) 体腔内で自由に移動可能な埋め込み可能な装置
CA2378339A1 (en) Self-occluding catheter
US3592185A (en) Ferromagnetic contrast media and method of use
ES2053325T3 (es) Instrumento para la realizacion de intervenciones medicas o quirurgicas por laparoscopia o coelioscopia.
ATE99544T1 (de) Liposomale radiologische kontrastmittel.
Tugwell et al. Electropermanent magnetic anchoring for surgery and endoscopy
Groning et al. Estimation of the gastric residence time of magnetic dosage forms using the Heidelberg capsule
DE102005032290A1 (de) Endoskopiekapsel sowie Verfahren zur Diagnose und/oder Therapie mittles einer Endoskopiekapsel
DE69006415T2 (de) Kontrastmittelzusammensetzung.
US4863716A (en) Determination of fallopian tubal patency by magnetic resonance imaging
Schoenfeld et al. Bladder perforation by an intrauterine device
ATE246488T1 (de) Mittel zur erzeugung eines langanhaltenden sättigungseffekts
IL126412A0 (en) Method of t-weighted magnetic resonance imaging of res organs
Driller et al. A review of medical applications of magnet attraction and detection
Danon et al. Hepatic and splenic involvement in cat-scratch disease: imaging features
RU94030723A (ru) Применение интерлейкина-8
Page et al. Chronic intussusception.
US7557685B2 (en) Mineral supplement cow magnet
Badawy et al. Omental reaction in cases of uterine perforation by the IUCD
RU2007194C1 (ru) Медицинская капсула
US3773042A (en) Apparatus for prevention of recurrence of prolapsed uterus
JPS6134401B2 (ru)